Gravity Gardens raises €2.6m for dry, chemical-free seed activation
The Nijmegen company has completed seven external trials of a process that adds no water, no chemicals and no coating to the seed, and is targeting market
Gravity Gardens, a Dutch seed technology company founded in 2024 and based in Nijmegen, has secured €2.6 million to scale its dry seed activation process, EU-Startups reported on 11 September 2026. The round combines equity investment with EFRO regional development funding. VP Capital, Brightlands Venture Partners and Graduate Ventures took part alongside private investors. The company has now raised more than €3 million in total, including earlier backing from StartLife and an innovation loan from Rabobank.
The process treats seed without adding water, chemicals or a coating. Rather than germination percentage, which most commercial seed lots already clear comfortably, the company targets vigour: how quickly and how strongly a crop establishes itself after sowing. Vigour is the property that degrades as a seed lot ages, and the one that decides whether a stand comes through a cold, wet spring. The company was developed with support from the European Space Agency Business Incubation Centre (ESA BIC) Noordwijk. It is led by founder and chief executive Paulino Valdés, with co-founder and chief technology officer Robin Le Vigouroux.
Gravity Gardens has completed seven external trials, including validation experiments carried out by Vertify, the Dutch applied research organisation for horticulture and seed. Market readiness is targeted during 2027, which puts commercial volumes two growing seasons away rather than next spring.
The new capital goes into industrial-scale equipment, developed with the Dutch engineering group Demcon, and into larger trial programmes across additional crops. The stated target market is European arable and horticultural crops.
Why it matters for AgTech founders: three things in this deal are worth reading closely. First, the customer is almost certainly not the farmer. A seed treatment is bought by seed companies and processors, which means a handful of accounts rather than thousands, long qualification cycles, and a purchase decision made on a sample rather than a demo. That is a far better fit for a €2.6 million seed round than a direct-to-grower motion would be. Second, dry and chemical-free is a regulatory statement as much as an agronomic one. A physical process that adds nothing to the seed does not carry the registration burden that kills most seed-enhancement ideas, and it stays clear of the tightening European rules on treated seed. Third, building the industrial equipment with Demcon rather than in-house forces the business model decision early: whoever owns the machine owns the margin, and a company at this stage has to choose between selling equipment, running a tolling service and licensing the process, because that choice sets how much capital the next round has to carry. The honest caution is the calendar. Seven trials and a 2027 readiness target mean roughly two more seasons before revenue can be judged, and vigour is sold as risk reduction, which is harder to price than a yield number. Independent trial data is what closes that gap, and it is the line item worth protecting when the money gets tight.
Gravity Gardens raises €2.6m for dry, chemical-free seed activation
The Nijmegen company has completed seven external trials of a process that adds no water, no chemicals and no coating to the seed, and is targeting market readiness during 2027.
Gravity Gardens, a Dutch seed technology company founded in 2024 and based in Nijmegen, has secured €2.6 million to scale its dry seed activation process, EU-Startups reported on 11 September 2026. The round combines equity investment with EFRO regional development funding. VP Capital, Brightlands Venture Partners and Graduate Ventures took part alongside private investors. The company has now raised more than €3 million in total, including earlier backing from StartLife and an innovation loan from Rabobank.
The process treats seed without adding water, chemicals or a coating. Rather than germination percentage, which most commercial seed lots already clear comfortably, the company targets vigour: how quickly and how strongly a crop establishes itself after sowing. Vigour is the property that degrades as a seed lot ages, and the one that decides whether a stand comes through a cold, wet spring. The company was developed with support from the European Space Agency Business Incubation Centre (ESA BIC) Noordwijk. It is led by founder and chief executive Paulino Valdés, with co-founder and chief technology officer Robin Le Vigouroux.
Gravity Gardens has completed seven external trials, including validation experiments carried out by Vertify, the Dutch applied research organisation for horticulture and seed. Market readiness is targeted during 2027, which puts commercial volumes two growing seasons away rather than next spring.
The new capital goes into industrial-scale equipment, developed with the Dutch engineering group Demcon, and into larger trial programmes across additional crops. The stated target market is European arable and horticultural crops.
Why it matters for AgTech founders: three things in this deal are worth reading closely. First, the customer is almost certainly not the farmer. A seed treatment is bought by seed companies and processors, which means a handful of accounts rather than thousands, long qualification cycles, and a purchase decision made on a sample rather than a demo. That is a far better fit for a €2.6 million seed round than a direct-to-grower motion would be. Second, dry and chemical-free is a regulatory statement as much as an agronomic one. A physical process that adds nothing to the seed does not carry the registration burden that kills most seed-enhancement ideas, and it stays clear of the tightening European rules on treated seed. Third, building the industrial equipment with Demcon rather than in-house forces the business model decision early: whoever owns the machine owns the margin, and a company at this stage has to choose between selling equipment, running a tolling service and licensing the process, because that choice sets how much capital the next round has to carry. The honest caution is the calendar. Seven trials and a 2027 readiness target mean roughly two more seasons before revenue can be judged, and vigour is sold as risk reduction, which is harder to price than a yield number. Independent trial data is what closes that gap, and it is the line item worth protecting when the money gets tight.
